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Serum angiotensin converting enzyme does not 
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A. F. SHORR, K. G. TORRINGTON AND J. M. PARKER 
Department of Medicine, Pulmonary and Critical Care Medicine Service, Walter Reed Army 
Medical Cenfer, Washington, U.S.A. 
Serum levels of angiotension converting enzyme (ACE) are elevated in many patients who suffer from 
sarcoidosis. Few studies have correlated ACE levels at diagnosis with the radiographic stage of the 
disease. The present authors reviewed the charts of all patients who had the diagnosis of sarcoidosis 
made between 1990 and 1995, and correlated ACE level at diagnosis with radiographic stage. Only 
patients with biopsy-proven sarcoid were included. One hundred and sixteen cases were identified, and 
complete data were available for 104 individuals. Serum ACE levels were increased in approximately 
63.5% of the study population. The relationships between both stage and ACE level, and stage and 
percentage of individuals with elevated ACE levels within that stage were not statistically significant 
(P~0.05). This large, retrospective study of patients with histologic evidence of sarcoidosis demonstrated 
no association between serum ACE level and radiographic stage. 
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Introduction 
Sarcoidosis is a disease of unknown etiology charac- 
terised by the presence of non-necrotising granulomas 
in various organs, predominantly the lung. Serum 
levels of angiotensin converting enzyme (ACE) are 
elevated at some point during the course of the 
disease in many patients, and are abnormal in 
approximately 55% (1) of individuals at time of 
diagnosis. Since the initial discovery by Lieberman (2) 
of the relationship between sarcoid and ACE, much 
attention has focused on the clinical utility of serum 
ACE levels. Presently, serum ACE levels are obtained 
routinely in patients undergoing evaluation for poss- 
ible sarcoid. The reported sensitivity for ACE levels 
ranges from approximately 40 to 60% (3,4), while the 
specificity has been noted to vary from approximately 
80 to 99% (3,4). Conditions other than sarcoid may 
produce abnormal ACE levels. High serum ACE has 
been found in diabetes mellitus, Gaucher’s disease, 
leprosy, asbestosis, berylliosis and silicosis (5). 
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Associations between ACE levels and certain 
aspects of sarcoidosis have been examined systemati- 
cally. Both the presence of erythema nodosum and 
hypercalcemia are believed to correlate with high 
ACE levels (3). Some postulate that the serum ACE 
level reflects the total body granuloma load (3). Few 
studies have correlated ACE levels at the time of 
diagnosis with the radiographic stage of disease, and 
those that have examined this issue have produced 
conflicting data (3-6). The present study aimed to 
define more clearly the relationship between serum 
ACE levels and the stage of sarcoidosis at the time of 
initial diagnosis. 
Methods 
The records of all Walter Reed Army Medical Center 
patients who had a new diagnosis of sarcoidosis made 
between January 1990 and December 1995, inclusive, 
were reviewed retrospectively. This institution is a 
military, tertiary care, university-affiliated teaching 
hospital. Demographic information and data regard- 
ing serum ACE levels and radiographic stage were 
extracted. The diagnosis of sarcoidosis was based 
upon the demonstration of non-necrotising granulo- 
mas in affected tissues with negative fungal and 
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mycobacterial tissue stains, and the patient presenting 
with a clinical syndrome consistent with sarcoidosis. 
Only patients with biopsy-proven sarcoidosis were 
included in the study population. All biopsy speci- 
mens were evaluated by board-certified pathologists. 
Sera specimens were sent to a reference laboratory 
(SmithKline Bioscience Laboratories, Washington, 
DC, U.S.A.), where ACE levels were measured using 
a spectrophotographic method. An elevated ACE 
level was defined as a measurement above 52 p 1 - ‘, 
which is the reference laboratory’s definition of 
abnormal. All ACE measurements were made both 
prior to bronchoscopy and the initiation of any 
therapy. Chest X-ray assessment relied upon standard 
staging criteria (7) for sarcoidosis, and was performed 
by board-certified radiologists. The stages were 
defined as follows: Stage 0, normal; Stage I, bilateral 
hilar adenopathy; Stage II, bilateral hilar adenopathy 
and parenchymal infiltrates; Stage III, parenchymal 
infiltrates only; Stage IV, pulmonary fibrosis. A 
Kruskal-Wallis ANOVA test was used to compare 
the distribution of ACE levels by stage. A Mantel- 
Hantzel test for linear association was employed to 
compare the proportion of individuals in each stage 
with an elevated ACE level to the entire population. 
This paper presents 95% confidence intervals (CI) for 
differences in these proportions, which provide a 
range for the true differences between stages, given 
the sample size. The a level was set at 0.05. 
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FIG. 1. Serum angiotensin converting enzyme 
(ACE) and radiographic stage. 
TABLE 1. Serum angiotensin converting enzyme 
(ACE) level and radiographic stage 
Stage 
Subjects with 
No. of Mean ACE increased 
subjects @ l- ‘) f SD ACE level (%) 
I 46 62.9 f 37.6 58.7 
II 39 83.0 r!r 55.2 64.1 
III 19 87.4 h 62.5 73.7 
Total 104 75.5 zt 50.3 63.5 
Results 
One hundred and sixteen cases were identified. Com- 
plete ACE and radiographic data were available for 
104 individuals, resulting in a yield of 89.7%. These 
104 patients constituted the study group, of whom 52 
were male. 
elevated ACE levels within each stage and the entire 
study population. This is confirmed by the wide range 
in the reported confidence intervals. 
Discussion 
Serum ACE levels were elevated in 66 subjects Previous studies of the relationship between serum 
(63.5%), and were normal in the remainder. The ACE levels and the radiographic stage of disease in 
distribution of ACE levels among the population is sarcoid patients have been inconclusive. Some 
shown in Fig. 1. The distribution by radiographic researchers have reported that higher ACE levels 
stage was as follows: Stage I, 46 (44.2%); Stage II, 39 correlate with advanced stage, while others have 
(37.5%); Stage III, 19 (18.3%); Stage IV, 0 (0.0%). The found no clear relationship (3-6) because of either 
correlation between radiographic stage and the pres- small sample size or the inclusion of patients with 
ence of an elevated serum ACE at time of diagnosis ‘clinically’ diagnosed, but not biopsy-proven, disease. 
is reported in Table 1. There was a 5% higher Romer (3) concludes that an ‘association exists 
occurrence (95% CI: - 5 to 26%) of elevated ACE in between the degree of chest X-ray abnormality and 
Stage II subjects compared to individuals with Stage I serum ACE’. Only 41% of the subjects in that study, 
disease. There was a 15% difference (95% CI: - 9 to however, had biopsy-proven sarcoidosis (3). The 
39%) in the proportion of subjects with elevated ACE inclusion of individuals with clinically diagnosed 
between Stages I and III. There was no statistical sarcoid undercuts both the internal and external 
difference (P=O.18) between ACE level and stage. validity of this effort. Patients without sarcoid 
Also, there was no statistically significant correlation may have comprised a portion of the study popula- 
(P=O.26) between the percentage of patients with tion. Rohrbach and DeRemee (4) also observed a 
concordance between radiographic stage and ACE 
levels. They fail to note how the diagnosis of sarcoid 
was made in their study subjects, and do not provide 
data as to when in the course of the disease (e.g. 
at time of diagnosis, after treatment with cortico- 
steroids, etc.) ACE measurements were made. These 
factors undermine the strength of their conclusions. 
Choudat et al. (6), on the other hand, note that the 
distribution of ACE levels did not correspond to the 
stage. They studied 50 individuals with sarcoid and 
also included patients with a clinical diagnosis of 
sarcoidosis, thus exposing their research to the same 
type of bias noted above. 
In a similar but not directly comparable study, 
Lieberman et al. (8) reported that changes in ACE 
levels correlated with changes in chest X-rays. They, 
however, studied a smaller sample of patients (n=31), 
used a lower definition of an abnormal ACE level 
(35 U ml - I), and did not state where in the course of 
disease their initial observations were made (e.g. at 
time of diagnosis, during active disease). Their study 
population was also relatively skewed in that it did 
not focus on consecutive, newly diagnosed patients, 
but rather included a selected sample drawn from 
their clinic population. The skew towards patients 
with advanced chest X-ray stage (approximately 33% 
with Stage III disease) demonstrates the potential for 
selection bias. More importantly, Lieberman et al. (8) 
did not provide data in their report regarding the 
distribution of ACE levels at the initiation of their 
study. This makes extrapolation of the relationship 
between chest X-ray stage and ACE level at time of 
diagnosis impossible. 
In the present study, no relationship was observed 
between elevated serum ACE levels and the radio- 
graphic stage of disease. This study benefited from a 
larger sample size and included only persons with 
histologic evidence of sarcoid. Angiotensin convert- 
ing enzyme levels were elevated in nearly 63.5% of the 
subjects. This study’s close agreement with Fanburg 
et al., who found ACE levels elevated at the time of 
SERUM ACE AND RADIOGRAPHIC STAGE IN SARCOIDOSIS 401 
diagnosis in approximately 55% of patients, suggests 
the generalizability of the present results (1). 
It is concluded that serum ACE levels measured at 
time of diagnosis do not correlate with the radio- 
graphic stage of disease. As the radiographic stage 
generally predicts prognosis in this disease (9), the 
lack of an association implies that the serum ACE 
level may be of limited prognostic significance. 
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